APO Research
Talk to an analyst

APO RESEARCH · REPORT

HIV Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global HIV Drugs Industry Growth and Trends Forecast to 2032

22 December 202595 pages

Choose your research edition.

Industry ResearchHIV Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal HIV Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal HIV Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HIV Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal HIV Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global HIV Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for HIV Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for HIV Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HIV Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of HIV Drugs include Johnson & Johnson, Merck, GlaxoSmithKline, Gilead Sciences and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global HIV Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The HIV Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global HIV Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to HIV Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global HIV Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

HIV Drugs Market by Company

Johnson & Johnson

Merck

GlaxoSmithKline

Gilead Sciences

Bristol-Myers Squibb

HIV Drugs Segment by Type

Fusion Inhibitors

Entry Inhibitors - CCR5 Co-Receptor Antagonist

Nucleoside Reverse Transcriptase Inhibitors

Non-Nucleoside Reverse Transcriptase Inhibitors

Multi-Class Combination Products

Protease Inhibitors

HIV Integrase Strand Transfer Inhibitors

HIV Drugs Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Others

HIV Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HIV Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of HIV Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of HIV Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Fusion Inhibitors Table 2. Major Company of Entry Inhibitors - CCR5 Co-Receptor Antagonist Table 3. Major Company of Nucleoside Reverse Transcriptase Inhibitors Table 4. Major Company of Non-Nucleoside Reverse Transcriptase Inhibitors Table 5. Major Company of Multi-Class Combination Products Table 6. Major Company of Protease Inhibitors Table 7. Major Company of HIV Integrase Strand Transfer Inhibitors Table 8. Global HIV Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global HIV Drugs Sales by Type (2021-2026) & (k units) Table 10. Global HIV Drugs Sales Market Share in Volume by Type (2021-2026) Table 11. Global HIV Drugs Sales by Type (2021-2026) & (US$ Million) Table 12. Global HIV Drugs Sales Market Share in Value by Type (2021-2026) Table 13. Global HIV Drugs Price by Type (2021-2026) & (US$/unit) Table 14. Global HIV Drugs Sales by Type (2027-2032) & (k units) Table 15. Global HIV Drugs Sales Market Share in Volume by Type (2027-2032) Table 16. Global HIV Drugs Sales by Type (2027-2032) & (US$ Million) Table 17. Global HIV Drugs Sales Market Share in Value by Type (2027-2032) Table 18. Global HIV Drugs Price by Type (2027-2032) & (US$/unit) Table 19. North America HIV Drugs Sales by Type (2021-2026) & (k units) Table 20. North America HIV Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Europe HIV Drugs Sales by Type (2021-2026) & (k units) Table 22. Europe HIV Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific HIV Drugs Sales by Type (2021-2026) & (k units) Table 24. Asia-Pacific HIV Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America HIV Drugs Sales by Type (2021-2026) & (k units) Table 26. Latin America HIV Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa HIV Drugs Sales by Type (2021-2026) & (k units) Table 28. Middle East and Africa HIV Drugs Sales by Type (2021-2026) & (US$ Million) Table 29. HIV Drugs Industry Trends Table 30. HIV Drugs Industry Drivers Table 31. HIV Drugs Industry Opportunities and Challenges Table 32. HIV Drugs Industry Restraints Table 33. Global HIV Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global HIV Drugs Revenue Market Share by Company (2021-2026) Table 35. Global HIV Drugs Sales by Company (2021-2026) & (k units) Table 36. Global HIV Drugs Sales Share by Company (2021-2026) Table 37. Global HIV Drugs Market Price by Company (2021-2026) & (US$/unit) Table 38. Global HIV Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global HIV Drugs Major Company Production Sites and Headquarters Table 40. Global HIV Drugs Company, Product Type & Application Table 41. Global HIV Drugs Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global HIV Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global HIV Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global HIV Drugs Sales by Region (2021-2026) & (k units) Table 46. Global HIV Drugs Sales Market Share in Volume by Region (2021-2026) Table 47. Global HIV Drugs Sales by Region (2021-2026) & (US$ Million) Table 48. Global HIV Drugs Sales Market Share in Value by Region (2021-2026) Table 49. Global HIV Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 50. Global HIV Drugs Sales by Region (2027-2032) & (k units) Table 51. Global HIV Drugs Sales Market Share in Volume by Region (2027-2032) Table 52. Global HIV Drugs Sales by Region (2027-2032) & (US$ Million) Table 53. Global HIV Drugs Sales Market Share in Value by Region (2027-2032) Table 54. Global HIV Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 55. Global HIV Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global HIV Drugs Sales by Application (2021-2026) & (k units) Table 57. Global HIV Drugs Sales Market Share in Volume by Application (2021-2026) Table 58. Global HIV Drugs Sales by Application (2021-2026) & (US$ Million) Table 59. Global HIV Drugs Sales Market Share in Value by Application (2021-2026) Table 60. Global HIV Drugs Price by Application (2021-2026) & (US$/unit) Table 61. Global HIV Drugs Sales by Application (2027-2032) & (k units) Table 62. Global HIV Drugs Sales Market Share in Volume by Application (2027-2032) Table 63. Global HIV Drugs Sales by Application (2027-2032) & (US$ Million) Table 64. Global HIV Drugs Sales Market Share in Value by Application (2027-2032) Table 65. Global HIV Drugs Price by Application (2027-2032) & (US$/unit) Table 66. North America HIV Drugs Sales by Application (2021-2026) & (k units) Table 67. North America HIV Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Europe HIV Drugs Sales by Application (2021-2026) & (k units) Table 69. Europe HIV Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific HIV Drugs Sales by Application (2021-2026) & (k units) Table 71. Asia-Pacific HIV Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America HIV Drugs Sales by Application (2021-2026) & (k units) Table 73. Latin America HIV Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa HIV Drugs Sales by Application (2021-2026) & (k units) Table 75. Middle East and Africa HIV Drugs Sales by Application (2021-2026) & (US$ Million) Table 76. Johnson & Johnson Company Information Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson HIV Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Johnson & Johnson HIV Drugs Product Portfolio Table 80. Johnson & Johnson Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck HIV Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Merck HIV Drugs Product Portfolio Table 85. Merck Recent Development Table 86. GlaxoSmithKline Company Information Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline HIV Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline HIV Drugs Product Portfolio Table 90. GlaxoSmithKline Recent Development Table 91. Gilead Sciences Company Information Table 92. Gilead Sciences Business Overview Table 93. Gilead Sciences HIV Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Gilead Sciences HIV Drugs Product Portfolio Table 95. Gilead Sciences Recent Development Table 96. Bristol-Myers Squibb Company Information Table 97. Bristol-Myers Squibb Business Overview Table 98. Bristol-Myers Squibb HIV Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Bristol-Myers Squibb HIV Drugs Product Portfolio Table 100. Bristol-Myers Squibb Recent Development Table 101. North America HIV Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 102. North America HIV Drugs Sales by Country (2021-2026) & (k units) Table 103. North America HIV Drugs Sales Market Share by Country (2021-2026) Table 104. North America HIV Drugs Sales Forecast by Country (2027-2032) & (k units) Table 105. North America HIV Drugs Sales Market Share Forecast by Country (2027-2032) Table 106. North America HIV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America HIV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 108. North America HIV Drugs Market Share by Country (2021-2026) Table 109. North America HIV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America HIV Drugs Market Share Forecast by Country (2027-2032) Table 111. Europe HIV Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. Europe HIV Drugs Sales by Country (2021-2026) & (k units) Table 113. Europe HIV Drugs Sales Market Share by Country (2021-2026) Table 114. Europe HIV Drugs Sales Forecast by Country (2027-2032) & (k units) Table 115. Europe HIV Drugs Sales Market Share Forecast by Country (2027-2032) Table 116. Europe HIV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe HIV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe HIV Drugs Market Share by Country (2021-2026) Table 119. Europe HIV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe HIV Drugs Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific HIV Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific HIV Drugs Sales by Country (2021-2026) & (k units) Table 123. Asia-Pacific HIV Drugs Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific HIV Drugs Sales Forecast by Country (2027-2032) & (k units) Table 125. Asia-Pacific HIV Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific HIV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific HIV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific HIV Drugs Market Share by Country (2021-2026) Table 129. Asia-Pacific HIV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific HIV Drugs Market Share Forecast by Country (2027-2032) Table 131. Latin America HIV Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Latin America HIV Drugs Sales by Country (2021-2026) & (k units) Table 133. Latin America HIV Drugs Sales Market Share by Country (2021-2026) Table 134. Latin America HIV Drugs Sales Forecast by Country (2027-2032) & (k units) Table 135. Latin America HIV Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America HIV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America HIV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America HIV Drugs Market Share by Country (2021-2026) Table 139. Latin America HIV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America HIV Drugs Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa HIV Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa HIV Drugs Sales by Country (2021-2026) & (k units) Table 143. Middle East and Africa HIV Drugs Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa HIV Drugs Sales Forecast by Country (2027-2032) & (k units) Table 145. Middle East and Africa HIV Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa HIV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa HIV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa HIV Drugs Market Share by Country (2021-2026) Table 149. Middle East and Africa HIV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa HIV Drugs Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. HIV Drugs Distributors List Table 154. HIV Drugs Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. HIV Drugs Image Figure 2. Global HIV Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HIV Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global HIV Drugs Sales (2021-2032) & (k units) Figure 5. Fusion Inhibitors Image Figure 6. Global Fusion Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 7. Entry Inhibitors - CCR5 Co-Receptor Antagonist Image Figure 8. Global Entry Inhibitors - CCR5 Co-Receptor Antagonist Sales YoY Growth (2021-2032) & (k units) Figure 9. Nucleoside Reverse Transcriptase Inhibitors Image Figure 10. Global Nucleoside Reverse Transcriptase Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 11. Non-Nucleoside Reverse Transcriptase Inhibitors Image Figure 12. Global Non-Nucleoside Reverse Transcriptase Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 13. Multi-Class Combination Products Image Figure 14. Global Multi-Class Combination Products Sales YoY Growth (2021-2032) & (k units) Figure 15. Protease Inhibitors Image Figure 16. Global Protease Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 17. HIV Integrase Strand Transfer Inhibitors Image Figure 18. Global HIV Integrase Strand Transfer Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 19. Global HIV Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global HIV Drugs Market Share by Type 2025 VS 2032 Figure 21. North America HIV Drugs Sales Market Share in Volume by Type in 2025 Figure 22. North America HIV Drugs Sales Market Share in Value by Type in 2025 Figure 23. Europe HIV Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Europe HIV Drugs Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific HIV Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific HIV Drugs Sales Market Share in Value by Type in 2025 Figure 27. Latin America HIV Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Latin America HIV Drugs Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa HIV Drugs Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa HIV Drugs Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 HIV Drugs Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Online Pharmacies Image Figure 34. Global Online Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 35. Hospital Pharmacies Image Figure 36. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 37. Retail Pharmacies Image Figure 38. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 41. Global HIV Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global HIV Drugs Market Share by Application 2025 VS 2032 Figure 43. North America HIV Drugs Sales Market Share in Volume by Application in 2025 Figure 44. North America HIV Drugs Sales Market Share in Value by Application in 2025 Figure 45. Europe HIV Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Europe HIV Drugs Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific HIV Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific HIV Drugs Sales Market Share in Value by Application in 2025 Figure 49. Latin America HIV Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Latin America HIV Drugs Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa HIV Drugs Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa HIV Drugs Sales Market Share in Value by Application in 2025 Figure 53. North America HIV Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. North America HIV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America HIV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America HIV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe HIV Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Europe HIV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe HIV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe HIV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific HIV Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Asia-Pacific HIV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific HIV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific HIV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America HIV Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Latin America HIV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America HIV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America HIV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa HIV Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 70. Middle East and Africa HIV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa HIV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa HIV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. HIV Drugs Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. HIV Drugs Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Fusion Inhibitors
  • Entry Inhibitors - CCR5 Co-Receptor Antagonist
  • Nucleoside Reverse Transcriptase Inhibitors
  • Non-Nucleoside Reverse Transcriptase Inhibitors
  • Multi-Class Combination Products
  • Protease Inhibitors
  • HIV Integrase Strand Transfer Inhibitors
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Johnson & Johnson
  • Merck
  • GlaxoSmithKline
  • Gilead Sciences
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global HIV Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global HIV Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 HIV Drugs Market by Type
  6. 1.3.1 Fusion Inhibitors
  7. 1.3.2 Entry Inhibitors - CCR5 Co-Receptor Antagonist
  8. 1.3.3 Nucleoside Reverse Transcriptase Inhibitors
  9. 1.3.4 Non-Nucleoside Reverse Transcriptase Inhibitors
  10. 1.3.5 Multi-Class Combination Products
  11. 1.3.6 Protease Inhibitors
  12. 1.3.7 HIV Integrase Strand Transfer Inhibitors
  13. 1.4 Global HIV Drugs Market Size by Type
  14. 1.4.1 Global HIV Drugs Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global HIV Drugs Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global HIV Drugs Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America HIV Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe HIV Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific HIV Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America HIV Drugs Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa HIV Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 HIV Drugs Industry Trends
  2. 2.2 HIV Drugs Industry Drivers
  3. 2.3 HIV Drugs Industry Opportunities and Challenges
  4. 2.4 HIV Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by HIV Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by HIV Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by HIV Drugs Price (2021-2026)
  4. 3.4 Global HIV Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global HIV Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global HIV Drugs Company, Product Type & Application
  7. 3.7 Global HIV Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global HIV Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 HIV Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 HIV Drugs Tier 1, Tier 2, and Tier 3
4 HIV Drugs Regional Status and Outlook
  1. 4.1 Global HIV Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global HIV Drugs Historic Market Size by Region
  3. 4.2.1 Global HIV Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global HIV Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global HIV Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global HIV Drugs Forecasted Market Size by Region
  7. 4.3.1 Global HIV Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global HIV Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global HIV Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 HIV Drugs by Application
  1. 5.1 HIV Drugs Market by Application
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.1.4 Others
  6. 5.2 Global HIV Drugs Market Size by Application
  7. 5.2.1 Global HIV Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global HIV Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global HIV Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America HIV Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe HIV Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific HIV Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America HIV Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa HIV Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson HIV Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson HIV Drugs Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck HIV Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck HIV Drugs Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline HIV Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline HIV Drugs Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Gilead Sciences
  20. 6.4.1 Gilead Sciences Company Information
  21. 6.4.2 Gilead Sciences Business Overview
  22. 6.4.3 Gilead Sciences HIV Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Gilead Sciences HIV Drugs Product Portfolio
  24. 6.4.5 Gilead Sciences Recent Developments
  25. 6.5 Bristol-Myers Squibb
  26. 6.5.1 Bristol-Myers Squibb Company Information
  27. 6.5.2 Bristol-Myers Squibb Business Overview
  28. 6.5.3 Bristol-Myers Squibb HIV Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bristol-Myers Squibb HIV Drugs Product Portfolio
  30. 6.5.5 Bristol-Myers Squibb Recent Developments
7 North America by Country
  1. 7.1 North America HIV Drugs Sales by Country
  2. 7.1.1 North America HIV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America HIV Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America HIV Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America HIV Drugs Market Size by Country
  6. 7.2.1 North America HIV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America HIV Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America HIV Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe HIV Drugs Sales by Country
  2. 8.1.1 Europe HIV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe HIV Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe HIV Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe HIV Drugs Market Size by Country
  6. 8.2.1 Europe HIV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe HIV Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe HIV Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific HIV Drugs Sales by Country
  2. 9.1.1 Asia-Pacific HIV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific HIV Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific HIV Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific HIV Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific HIV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific HIV Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific HIV Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America HIV Drugs Sales by Country
  2. 10.1.1 South America HIV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America HIV Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America HIV Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America HIV Drugs Market Size by Country
  6. 10.2.1 South America HIV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America HIV Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America HIV Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa HIV Drugs Sales by Country
  2. 11.1.1 Middle East and Africa HIV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa HIV Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa HIV Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa HIV Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa HIV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa HIV Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa HIV Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 HIV Drugs Value Chain Analysis
  2. 12.1.1 HIV Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 HIV Drugs Production Mode & Process
  7. 12.2 HIV Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 HIV Drugs Distributors
  10. 12.2.3 HIV Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst